Sunday, October 20th | 21 Tishri 5780

Subscribe
July 7, 2017 1:41 pm

Israeli Doctoral Student Develops Groundbreaking Test for Parkinson’s Disease

avatar by JNS.org

Stereotactic surgery, which is used to treat Parkinson’s disease. Photo: Wikimedia Commons.

JNS.org – Suaad Abd-Elhadi, a doctoral student at the Hebrew University of Jerusalem, has won an innovation award for developing a new groundbreaking tool that could lead to earlier detection of Parkinson’s disease.

Abd-Elhadi’s “lipid ELISA” test could also improve monitoring of the disease’s progression and a patient’s response to treatment. ELISA stands for enzyme-linked immunosorbent assay. Abd-Elhadi received Hebrew University’s Kaye Innovation Award, which was established by British pharmaceutical industrialist Isaac Kaye in 1994.

Parkinson’s is the second-leading degenerative disease among the elderly in the US, after Alzheimer’s. Using Abd-Elhadi’s diagnosis technique, Parkinson’s can be detected before symptoms start showing.

“Earlier diagnosis can help by seeing how a given drug affects the progress of the disease,” Abd-Elhadi said, Haaretz reported.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.